MRT-6160

· Monte Rosa Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRT-6160, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: First-in-human Study of MRT-6160 in Healthy Subjects [Phase 1]